Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;33(2):156-161.
doi: 10.1097/ACO.0000000000000830.

Multidrug-resistant bacteria in ICU: fact or myth

Jan J De Waele  1 , Jerina Boelens  2 , Isabel Leroux-Roels  2   3
Affiliations
Review

Multidrug-resistant bacteria in ICU: fact or myth

Jan J De Waele et al. Curr Opin Anaesthesiol. 2020 Apr.

Abstract

Purpose of review: Antimicrobial resistance (AMR) is increasing in ICUs around the world, but the prevalence is variable. We will review recent literature and try to answer the question whether this is a myth or a new reality, as well as discuss challenges and potential solutions.

Recent findings: AMR is diverse, and currently Gram-negative multidrug-resistant organisms (MDROs) are the main challenge in ICUs worldwide. Geographical variation in prevalence of MDROs is substantial, and local epidemiology should be considered to assess the current threat of AMR. ICU patients are at a high risk of infection with MDRO because often multiple risk factors are present. Solutions should focus on reducing the risk of cross-transmission in the ICU through strict infection prevention and control practices and reducing exposure to antimicrobials as the major contributor to the development of AMR.

Summary: AMR is a reality in most ICUs around the world, but the extent of the problem is clearly highly variable. Infection prevention and control as well as appropriate antimicrobial use are the cornerstones to turn the tide.

PubMed Disclaimer

References

    1. Meyer N, Harhay MO, Small DS, et al. Temporal trends in incidence, sepsis-related mortality, and hospital-based acute care after sepsis. Crit Care Med 2018; 46:354–360.
    1. Guillemot D, Crémieux AC, Courvalin P. Evolution of antimicrobial resistance: impact on antibiotic use. Semin Respir Crit Care Med 2002; 23:449–456.
    1. Tacconelli E, Sifakis F, Harbarth S, et al. EPI-Net COMBACTE-MAGNETG. Surveillance for control of antimicrobial resistance. Lancet Infect Dis 2018; 18:e99–e106.
    1. Rochford C, Sridhar D, Woods N, et al. Global governance of antimicrobial resistance. Lancet 2018; 391:1976–1978.
    1. Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010; 362:1804–1813.